Dyne Therapeutics, Inc. (DYN): Total Assets
$1.19B
As of 2025-12-31
$994.01M
As of 2026-06-30
+57.1%
3-year compound annual growth
+27.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.19B | +71.7% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $691.23M | +318.7% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $165.08M | -46.1% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $306.32M | -28.0% | 2024-03-05, Balance as of period end |
| 2021-12-31 | $425.66M | +20.5% | 2023-03-02, Balance as of period end |
| 2020-12-31 | $353.33M | n/m | 2022-03-10, Balance as of period end |
| 2019-12-31 | $16.44M | n/a | 2021-03-04, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | 2025-12-31 | $1.19B | +71.7% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.20B | -8.7% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $1.17B | -1.1% |
| Arcus Biosciences, Inc. (RCUS) | 2025-12-31 | $1.14B | -1.0% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.26B | +20.9% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $1.26B | -18.6% |
| IDEAYA Biosciences, Inc. (IDYA) | 2025-12-31 | $1.11B | -1.3% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $1.27B | +27.3% |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | $1.30B | -22.0% |
Compare DYN, INDV, ZLAB, RCUS side by side · Screen every company in Pharmaceutical Preparations ↗